However, IDH1/2 mutations are not exclusively found in oligodendroglial and oligoastrocytic gliomas, but also in the majority of grade II and III astrocytic tumors, indicating the existence of a common initiating event among these histologically and clinically diverse glioma subtypes [6]. Here, IDH1 is linked to central nervous system cancer.